In the BioHarmony Drug Report Database

"Preview" Icon

Guanabenz

Wytensin (guanabenz) is a small molecule pharmaceutical. Guanabenz was first approved as Wytensin on 1982-09-07. It is used to treat hypertension in the USA. The pharmaceutical is active against alpha-2B adrenergic receptor, alpha-2C adrenergic receptor, and alpha-2A adrenergic receptor.

 

Trade Name

 

Wytensin
 

Common Name

 

guanabenz
 

ChEMBL ID

 

CHEMBL420
 

Indication

 

hypertension
 

Drug Class

 

Cannabinol derivatives; antihypertensives (guanidine derivatives)

Image (chem structure or protein)

Guanabenz structure rendering